Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative

Edmondson, R.J.; Crosbie, E.J.; Nickkho-Amiry, M.; Kaufmann, A.; Stelloo, E.; Nijman, H.W.; ... ; Kitchener, H.C. (2017)

Article / Letter to editor

• Endometrial cancer
• Molecular profiling
• Prognosis
• p53
• p21
• pp63
• L1CAM
• Pole

• All authors: Edmondson, R.J.; Crosbie, E.J.; Nickkho-Amiry, M.; Kaufmann, A.; Stelloo, E.; Nijman, H.W.; Leary, A.; Auguste, A.; Mileshkin, L.; Pollock, P.; MacKay, H.J.; Powell, M.E.; Bosse, T.; Creutzberg, C.L.; Kitchener, H.C.
• Date: 2017-08-31
• Journal: Gynecologic Oncology
• Volume: 146
• Issue: 2
• Pages: 327 - 333
• DOI: doi:10.1016/j.ygyno.2017.05.014